RECENT
ADVANCES
IN
SCREENING
FOR
INBORN
ERRORS
OF
METABOLISM
A
SCREENING
TEST
IS
ANY
DIAGNOSTIC
PROCEDURE
WHICH
WE
APPLY
WITHOUT
A
SPECIFIC
CLINICAL
INDICATION
FROM
THE
POINT
OF
VIEW
OF
THE
INDIVIDUAL
PATIENT
CONCERNED
NONSELECTIVE
WHOLE
POPULATION
SCREENING
FOR
INBORN
ERRORS
OF
METABOLISM
SELECTIVE
SCREENING
FOR
INBORN
ERRORS
OF
METABOLISM
SCREENING
FOR
NONAMINO
ORGANIC
ACIDURIAS
AND
SELECTIVE
SCREENING
FOR
INBORN
ERRORS
OF
METABOLISM
BECAUSE
OF
GENETIC
INDICATIONS
ARE
DISCUSSED
THE
MAIN
POINTS
WHICH
EMERGE
FOR
THE
FUTURE
FROM
THIS
REVIEW
ARE
THE
NEED
TO
DEVELOP
MULTIDISEASE
SCREENING
PROGRAMMES
TO
DETECT
THE
VERY
RARE
DISEASES
THAT
POSTNATAL
PRENATAL
AND
CARRIER
SCREENING
SHOULD
BE
CONSIDERED
AND
DEVELOPED
COLLECTIVELY
AND
THERE
US
AN
URGENT
NEEDS
TO
DEVELOP
SCREENING
FOR
THALLASAEMIA
SICKLE
CELL
DISEASE
CYSTIC
FIBROSIS
AND
CONGENITAL
HYPOTHYROIDISM
